A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia
Phase 1
- Conditions
- MyopiaHyperopia
- Interventions
- Drug: 1% EXP039Other: Saline control
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Canyon City Eyecare
- Target Recruit Count
- 60
- Registration Number
- NCT04883996
- Locations
- 🇺🇸
Canyon City Eyecare, Azusa, California, United States
© Copyright 2025. All Rights Reserved by MedPath